Skip to main content
. Author manuscript; available in PMC: 2018 Nov 5.
Published in final edited form as: Pediatrics. 2018 Apr 4;141(5):e20173006. doi: 10.1542/peds.2017-3006

TABLE 2.

Association Between Sex, Uropathogen Type, and Etiology of Neurogenic Bladder and Pyuria

Predictors Cultures ≥ 10 000 CFU/mL Cultures ≥ 100 000 CFU/mL
Odds of Pyuria 95% CI Odds of Pyuria 95% CI
Sex
 Female Reference Reference
 Male 1.69a (1.32 – 2.16)a 1.70a (1.29 – 2.26)a
Uropathogen
 E coli Reference Reference
 P aeruginosa 1.00 (0.63 – 1.61) 0.86 (0.48 – 1.59)
 Staphylococcus saprophyticus 0.93 (0.13 – 18.60) b b
 Enterococcus species 0.66a (0.47 – 0.91)a 0.44a (0.30 – 0.64)a
 Klebsiella species 0.95 (0.67 – 1.36) 0.81 (0.54 – 1.20)
 Proteus species 1.74 (0.93 – 3.56) 2.16a (1.05 – 5.03)a
 Enterobacter species 1.39 (0.77 – 2.66) 0.94 (0.53 – 1.73)
 Other 0.86 (0.63 – 1.17) 0.83 (0.58 – 1.19)
Etiology of neurogenic bladder
 Myelomeningocele Reference Reference
 Anorectal malformation 0.94 (0.63 – 1.43) 1.16 (0.72 – 1.92)
 Tethered cord 1.22 (0.79 – 1.91) 1.67a (1.02 – 2.83)a
 Bladder exstrophy 3.24 (0.95 – 20.28) 3.46 (0.97 – 22.16)
 Cloacal malformation 1.09 (0.71 – 1.70) 1.84a (1.04 – 3.42)a
 Spinal cord injury 0.98 (0.38 – 3.06) 2.95 (1.09 – 10.3)
 Eagle-Barrett syndrome 1.61 (0.45 – 10.28) b b
 Other 0.76a (0.59 – 0.98)a 1.02 (0.77 – 1.35)
Presence of mitrofanoff 2.41a (1.81 – 3.24)a 3.14a (2.19 – 4.63)a
Presence of hydronephrosis 1.01 (0.51 – 2.21) 1.22 (0.51 – 3.42)
Presence of VUR 2.20a (1.63 – 3.24)a 4.55a (3.07 – 6.98)a

—, not applicable.

a

Indicates statistical significance.

b

CI unable to be computed because of a small sample size.